Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (Q2105797)

From MaRDI portal
Revision as of 01:56, 17 December 2024 by Import241208061232 (talk | contribs) (Normalize DOI.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines
scientific article

    Statements

    Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    8 December 2022
    0 references
    tumor growth
    0 references
    doxorubicin
    0 references
    mathematical modeling
    0 references
    Bayesian calibration
    0 references
    0 references
    0 references

    Identifiers